XSHE
000423
Market cap4.44bUSD
Oct 09, Last price
46.68CNY
1D
0.56%
1Q
-0.24%
Jan 2017
-13.35%
Name
Dong-E-E-Jiao Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1952 and headquartered in Liaocheng, China, Dong-E-E-Jiao Co.,Ltd. is a prominent manufacturer and distributor of traditional Chinese remedies, biopharmaceuticals, and wellness food products throughout the Chinese market.
Key people
Hongyan Ding
Chief Financial Officer, Vice President, Secretary of the Board, Director · since 2023
Longjian Chen
Vice President · since 2025
Guozheng Li
Vice President · since 2025
Xinhua Li
Vice President · since 2018
Qingchuan Li
Vice President · since 2023
Guangyuan Liu
Vice President · since 2018
Liang Zheng
Vice President · since 2025
Chairman of the Board · since 2024
Jinni Sun
President, Director · since 2024
Director · since 2025
Peiqing Xu
Director · since 2024
Xianglin Cheng
Independent Director · since 2025
De'an Guo
Independent Director · since 2021
Xiaobo Sun
Independent Director · since 2024
Guangwei Wen
Independent Director · since 2021
Headquarters & legal address
东阿县阿胶街78号
聊城市, SD 252200
CN
聊城市, SD 252200
CN
Address
NO.78 Ejiao Street DongE County ShanDong Province,China
Liaocheng, SD 252200
CN
Liaocheng, SD 252200
CN
Other language
DongE E jiao Corporation limited.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||